Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease.
Biochem Pharmacol. 2020 Aug;178:114103. doi: 10.1016/j.bcp.2020.114103. Epub 2020 Jun 17.
Biochem Pharmacol. 2020.
PMID: 32562787
Free article.